Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Metrics Regulatory News (OMG)

Share Price Information for Oxford Metrics (OMG)

Share Price is delayed by 15 minutes
Get Live Data
45.60    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.40 (3.077%)
Market Cap: £51.04m
OMG Live PriceLast checked at - London Stock Exchange

Intraday Oxford Metrics Share Chart

Total Voting Rights

13 Jan 2021 16:20

RNS Number : 6041L
Oxford Metrics PLC
13 January 2021
 

13 January 2021

Oxford Metrics plc

("Oxford Metrics" or the "Group")

Issue of Ordinary Shares & Total Voting Rights - Replacement

The following announcement replaces the "Issue of Ordinary Shares & Total Voting Rights" released on 11 January 2021 at 07:00. The only change relates to the admission date which should read as 14 January 2021.

 

Oxford Metrics plc (AIM:OMG), the international software company servicing government, life sciences, entertainment and engineering markets, announces that on 08 January an employee of the Company exercised 10,000 options of ordinary shares in the Company.

Pursuant to the exercise of these share options, the Company confirms that application has been made to the London Stock Exchange for the admission of 10,000 new ordinary shares to trading on AIM. Admission is expected to take place at 8.00am on 14 January 2021.

 

Total Voting Rights

Following Admission, the Company will have 126,430,168 Ordinary Shares in issue with each share carrying the right to one vote. The Company has no Ordinary Shares held in treasury. The total number of voting rights in the Company following Admission will therefore be 126,430,168.

 

For further information, please contact:

Oxford Metrics

Nick Bolton, CEO

David Deacon, CFO

 

+44 (0)18 6526 1800

Numis Securities Limited

Simon Willis

Hugo Rubinstein

Matthew O'Dowd

 

+44 (0)20 7260 1000

FTI Consulting

Matt Dixon / Emma Hall / Jamille Smith / Greg Hynes

 

+44 (0)20 3727 1000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRMZGMMVFRGMZM
Date   Source Headline
6th Jun 20237:00 amRNSInterim Results
25th May 202311:59 amRNSInvestor Presentation
17th May 20237:00 amRNSVicon contract win
12th May 20237:00 amRNSNotification of Results
13th Feb 20232:15 pmRNSPDMR Shareholding and Director Dealing
9th Feb 20232:59 pmRNSResult of AGM
9th Feb 20237:00 amRNSAGM Statement
17th Jan 202311:22 amRNSPDMR Shareholding, Issue of Ordinary Shares & TVR
22nd Dec 20227:00 amRNSDividend update
16th Dec 202211:39 amRNSIssue of Ordinary Shares & Total Voting Rights
13th Dec 20225:51 pmRNSPosting Annual Report & Accounts and Notice of AGM
9th Dec 202211:20 amRNSPDMR Shareholding, Issue of Ordinary Shares & TVR
6th Dec 20225:06 pmRNSPDMR Shareholding, Issue of Ordinary Shares & TVR
6th Dec 20227:00 amRNSPreliminary Results
28th Nov 20227:00 amRNSInvestor Presentation
9th Nov 20227:00 amRNSNotice of Results
27th Sep 20227:00 amRNSTrading Update
17th Aug 20227:00 amRNSVicon Contract Win
28th Jul 202212:46 pmRNSIssue of Ordinary Shares & Total Voting Rights
20th Jul 20227:00 amRNSIssue of Ordinary Shares & Total Voting Rights
19th Jul 202212:42 pmRNSIssue of Ordinary Shares & Total Voting Rights
19th Jul 20227:00 amRNSVicon launches new Valkyrie solution
5th Jul 20225:04 pmRNSHolding(s) in Company
4th Jul 20225:53 pmRNSExercise of Options, Director Dealing and TVR
24th Jun 20227:00 amRNSIssue of Ordinary Shares & Total Voting Rights
23rd Jun 20227:00 amRNSInterim Results
7th Jun 20227:00 amRNSInvestor Presentation
6th Jun 20224:40 pmRNSSecond Price Monitoring Extn
6th Jun 20224:35 pmRNSPrice Monitoring Extension
31st May 20223:11 pmRNSHolding(s) in Company
31st May 202211:51 amRNSHolding(s) in Company
30th May 20224:40 pmRNSSecond Price Monitoring Extn
30th May 20224:35 pmRNSPrice Monitoring Extension
30th May 20227:00 amRNSSale of Yotta
17th May 20227:00 amRNSNotification of Results
9th Feb 20222:33 pmRNSResult of AGM
9th Feb 20222:00 pmRNSAnnual General Meeting Statement
12th Jan 20227:00 amRNSUpdate to Notice of 2022 AGM
10th Jan 20223:30 pmRNSIssue of Ordinary Shares & Total Voting Rights
13th Dec 20215:30 pmRNSPosting Annual Report & Accounts and Notice of AGM
9th Dec 20217:00 amRNSInvestor Presentation
6th Dec 20214:00 pmRNSPDMR Shareholding, Issue of Ordinary Shares & TVR
2nd Dec 20215:15 pmRNSGrant of LTIP Awards to Directors
2nd Dec 202112:45 pmRNSPDMR Shareholding, Issue of Ordinary Shares & TVR
2nd Dec 20217:00 amRNSPreliminary Results
27th Oct 202111:31 amRNSIssue of Ordinary Shares & Total Voting Rights
26th Oct 20217:00 amRNSVicon Contract Win
19th Oct 20217:00 amRNSTrading Statement and Capital Markets Day
1st Oct 20217:00 amRNSAppointment of Non-Executive Director
1st Sep 20217:00 amRNSAcquisition of CONTEMPLAS GmbH

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.